East Windsor, NJ - The FDA has given i-STAT Corporation clearance to market its prothrombin time (PT) test for use with the company's portable clinical analyzer according to a company press release.

AS A result of the widespread use of dicumarol in the prevention and treatment of thromboembolism, clinicians have become increasingly interested in the role of prothrombin in blood coagulation.

THE increasing enthusiasm for treating thromboembolic diseases with prothrombin-reducing drugs for long periods in ambulatory patients has emphasized the lack of clear definition of the therapeutic ...